Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish Woman with primary breast and ovarian cancer

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 4, 2007, Pages

  Spannuth, Whitney A ^a   Thaker, Premal H ^a   Sood, Anil K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Ashkenazi Jewish female; BRCA mutation; ovarian carcinoma

Indexed keywords

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JEWS; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33947669328     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.01.026     Document Type: Article

References (22)

1. Berek J.S. Epithelial ovarian cancer. In: Berek J.S., and Hacker N.F. (Eds). Practical gynecologic oncology. 3rd ed. (2000), Lippincott Williams and Wilkins, Philadelphia 460-463
2. Piura B., Rabinovich A., and Yanai-Inbar I. Three primary malignancies related to BRCA mutation successively occurring in a BRCA1 185delAG mutation carrier. Eur J Obstet Gynecol 97 (2001) 241-244
3. Scully R., and Livingston D.M. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408 (2000) 429-432
4. Bandera C.A. Advances in the understanding of risk factors for ovarian cancer. J Reprod Med 50 (2005) 399-406
5. Ford D., Easton D.F., Bishop D.T., Narod S.A., and Goldgar D.E. Risks of cancer in BRCA1 mutation carriers: breast cancer linkage consortium. Lancet 343 (1994) 692-695
6. Ford D., Easton D.F., Stratton M., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: the breast cancer linkage consortium. Am J Human Genet 62 (1998) 676-689
7. Matzuk M.M. Gynecologic diseases get their genes. Nat Med 11 (2005) 24-26
8. Gayther S.A., Mangion J., Russell P., et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15 (1997) 103-105
9. Risch H.A., McLaughlin J.R., David E., Cole C., Rosen B., and Bradley L. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Human Genet 68 (2001) 700-710
10. Friedman E., Bar-Sade Bruchim R., Kruglikova A., et al. Double heterozygotes for the Ashkenazi founder mutations BRCA1 and BRCA2 genes. Am J Hum Genet 63 (1998) 1224-1227
11. Ramus S.J., Friedman L.S., Gather S.A., et al. A breast/ovarian patient with germline mutations in both BRCA1 and BRCA2. Nat Genet 15 (1997) 14-15
12. Randall T.C., Bell K.A., Rebane B.A., Rubin S.C., and Boyd J. Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient. Gynecol Oncol 70 (1998) 432-434
13. Leide A., Rehal P., Vesprini D., Jack E., Abrahamson J., and Narod S. A breast cancer patient of Scottish descent with germ-like mutations in BRCA1 and BRCA2. Am J Hum Genet 62 (1998) 1543-1544
14. Tesoriero A., Andersen C., Southey M., et al. De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation. Am J Hum Genet 65 (1999) 567-569
15. Moslehi R., Russo D., Phelan C., Jack E., Antman K., and Narod S. An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2. Clin Genet 57 (2000) 70-73
16. Bell D.W., Erban J., Sgroi D.C., and Haber D.A. Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2. Cancer Res 62 (2002) 2741-2743
17. Caldes T., de la H.M., Tosar A., et al. A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genes. J Med Genet 39 (2002) e44
18. Choi D.H., Lee M.H., Bale A.E., Carter D., and Haffy B.G. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22 (2004) 1638-1645
19. Frank T.S., Deffenbaugh A.M., Reid J.E., et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20 (2002) 1480-1490
20. Leegte B., Van der hout A.H., Deffenbaugh A.M., et al. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. J Med Genet 42 (2005) e20
21. Warner E., Foulkes W., Goodwin P., et al. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91 (1999) 1241-1247
22. Frank T.S., Manley S.A., Olopade O.I., et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16 (1998) 2417-2425